Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 21,079 | Dovepress* | 17,930+ | 1,834 | 19,764 | |
| PubMed Central* | 3,149 | 749 | 3,898 | ||
| Totals | 21,079 | 2,583 | 23,662 | ||
| *Since 21 August 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 7 | 0 | 0 | 0 | 1 | 6 |
View citations on PubMed and Google Scholar